Mebendazole poisoning in infancy

Kalla, S. El; Menon, N. S.

doi:10.1080/02724936.1990.11747449

Cited by 5 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the case of 979 treatments reported in group B, side-effects were actively searched for but were not found. The only report of side-effects concerns one episode of convulsion reported from Dubai (el Kalla, 1990). In this case the infant treated with mebendazole was 7 weeks old and the problem may have been caused by increased drug absorption (see Table 2).…”

Section: Introductionmentioning

confidence: 99%

Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis

2003

View full text Add to dashboard Cite

Considerable experience and limited quantitative evidence indicate that infections with the soiltransmitted helminths Ascaris lumbricoides and Trichuris trichiura usually start to become established in children aged 12 months and older. Since children living in countries where the infections are endemic are at risk of morbidity, even those as young as 12 months may need to be considered for inclusion in public health programmes designed to reduce morbidity by means of regular anthelminthic chemotherapy. This situation raises the question as to whether such young children should be given anthelminthic drugs. Systems for the absorption, distribution, metabolism and elimination of drugs do not fully develop until children are in their second year of life. Current knowledge, however, reveals that the incidence of side effects linked to benzimidazole drugs in young children is likely to be the same as in older children. Accordingly, we conclude that albendazole and mebendazole may be used to treat children as young as 12 months if local circumstances show that relief from ascariasis and trichuriasis is justified.

show abstract

Section: Introductionmentioning

confidence: 99%